[1] CATALANOTTO C,COGONI C,ZARDO G.microRNA in control of gene expression:An overview of nuclear functions[J].International Journal of Molecular Sciences,2016,17(10):1712. [2] JONAS S,I ZAURRALDE E.Towards a molecular understanding of microRNA-mediated gene silencing[J].Nature Reviews Genetics,2015,16(7):421-433. [3] COHEN E E,ZHU H,LINGEN M W,et al.A feed-forward loop involving protein kinase Calpha and microRNAs regulates tumor cell cycle[J].Cancer Research,2009,69(1):65-74. [4] JAHANGIRI B,KHALAJ-KONDORI M,ASADOLLAHI E,et al.MSC-derived exosomes suppress colorectal cancer cell proliferation and metastasis via miR-100/mTOR/miR-143 pathway[J].International Journal of Pharmaceutics,2022,627:122214. [5] CHEN C P,SU T C,YANG M J,et al.Green tea epigallocatechin gallate suppresses 3T3-L1 cell growth via microRNA-143/MAPK7 pathways[J].Experimental Biology and Medicine,2022,247(18):1670-1679. [6] YAN Y,YUAN J,LUO X,et al.microRNA-140 regulates PDGFRα and is involved in adipocyte differentiation[J].Frontiers in Molecular Biosciences,2022,9:907148. [7] SINGH R,HA S E,WEI L,et al.miR-10b-5p rescues diabetes and gastrointestinal dysmotility[J]. Gastroenterology,2021,160(5):1662-1678. [8] HANIN G,YAYON N,TZUR Y,et al.miRNA-132 induces hepatic steatosis and hyperlipidaemia by synergistic multitarget suppression[J].Gut,2018,67(6):1124-1134. [9] NOSALSKI R,SIEDLINSKI M,DENBY L,et al.T-cell-derived miRNA-214 mediates perivascular fibrosis in hypertension[J]. Circulation Research,2020,126(8):988-1003. [10] RUPAIMOOLE R,SLACK F J.microRNA therapeutics:Towards a new era for the management of cancer and other diseases[J].Nature Reviews Drug Discovery,2017,16(3):203-222. [11] BAUTISTA-BECERRIL B,PEREZ-DIMAS G,SOMMERHALDER-NAVA P C,et al.miRNAs,from evolutionary junk to possible prognostic markers and therapeutic targets in COVID-19[J].Viruses,2021,14(1):41. [12] GONZALA-CALVO D D,BENITEZ I D,PINILLA L,et al.Circulating microRNA profiles predict the severity of COVID-19 in hospitalized patients[J].Translational Research,2021,236:147-159. [13] REN F J,YAO Y,CAI X Y,et al.Emerging role of miR-192-5p in human diseases[J].Frontiers in Pharmacology,2021,12:614068. [14] CHARTOUMPEKIS D V,ZARAVINOS A,ZIROS P G,et al.Differential expression of microRNAs in adipose tissue after long-term high-fat diet-induced obesity in mice[J].PLoS One,2012,7(4):e34872. [15] WANG S,PAN C,MA X,et al.Identification and functional verification reveals that miR-195 inhibiting THRSP to affect fat deposition in Xinyang buffalo[J].Frontiers in Genetics,2021,12:736441. [16] DAI J,HUANG X,ZHANG C,et al.Berberine regulates lipid metabolism via miR-192 in porcine oocytes matured in vitro[J].Veterinary Medicine and Science,2021,7(3):950-959. [17] 王艳芳,周瑞莲,赵彦宏.miR-171基因家族进化分析及靶基因预测[J].生命科学研究,2015,19(6):479-483. WANG Y F,ZHOU R L,ZHAO Y H.Molecular evolutionary of miR-171 gene family and prediction of their target gene[J].Life Science Research,2015,19(6):479-483.(in Chinese) [18] 郭思玮,张馨心,张聪聪,等.miRNA序列及其靶基因结合位点的单核苷酸多态性对畜禽生产性状调控的研究进展[J].中国畜牧杂志,2022,58(6):43-48. GUO S W,ZHANG X X,ZHANG C C,et al.Research progress on regulation of single nucleotide polymorphisms in miRNA sequences and its target gene binding site on livestock production traits[J].Chinese Journal of Animal Science,2022,58(6):43-48.(in Chinese) [19] 陈晨,胡雄贵,朱吉,等.猪脂肪发育相关miRNAs的功能研究进展[J].畜牧兽医学报,2015,46(12):2117-2126. CHEN C,HU X G,ZHU J,et al.Progress on research of miRNA associated with fat development in pigs[J].Acta Veterinaria et Zootechnica Sinica,2015,46(12):2117-2126.(in Chinese) [20] 陈晨.miR-135a和miR-183对3T3-L1前脂肪细胞分化及脂肪形成的调控作用研究[D].武汉:华中农业大学,2013. CHEN C.Studies of the regulatory effects of miR-135a and miR-183 on 3T3-L1 preadipocytes differentiation and adipogenesis[D].Wuhan:Huazhong Agricultural University,2013.(in Chinese) [21] CHEN C,PENG Y D,PENG Y L,et al.miR-135a-5p inhibits 3T3-L1 adipogenesis through activation of canonical Wnt/beta-catenin signaling[J].Journal of Molecular Endocrinology,2014,52(3):311-320. [22] CHEN C,XIANG H,PENG Y L,et al.Mature miR-183,negatively regulated by transcription factor GATA3,promotes 3T3-L1 adipogenesis through inhibition of the canonical Wnt/beta-catenin signaling pathway by targeting LRP6[J].Cellular Signalling,2014,26(6):1155-1165. [23] CHEN C,DENG Y,HU X,et al.miR-128-3p regulates 3T3-L1 adipogenesis and lipolysis by targeting Pparg and Sertad2[J]. Journal of Physiology and Biochemistry,2018,74(3):381-393. [24] LIU F F,PEI Y.microRNA192 promotes metastasis and invasion of breast cancer via targeting tensin1 and enhancing cell division control protein 42 homolog (CDC42) expression[J]. Journal of Biomaterials and Tissue Engineering,2022,12(8):1505-1516. [25] ZHANG X J,PENG Y,HUANG Y,et al.SMG-1 inhibition by miR-192/-215 causes epithelial-mesenchymal transition in gastric carcinogenesis via activation of Wnt signaling[J].Cancer Medicine,2018,7(1):146-156. [26] LIAN J W,JING Y,DONG Q Z,et al.miR-192,a prognostic indicator,targets the SLC39A6/SNAIL pathway to reduce tumor metastasis in human hepatocellular carcinoma[J].Oncotarget,2016,7(3):2672-2683. [27] HUANG Q,HOU S,ZHU X,et al.microRNA-192 promotes the development of nasopharyngeal carcinoma through targeting RB1 and activating PI3K/Akt pathway[J].World Journal of Surgical Oncology,2020,18(1):29. [28] ZHENG X F,LIU K X,WANG X M,et al.microRNA192 acts as a tumor suppressor in colon cancer and simvastatin activates miR192 to inhibit cancer cell growth[J].Molecular Medicine Reports,2019,19(3):1753-1760. [29] JI D,JIANG L,LI Y.miR-192-5p suppresses the growth of bladder cancer cells via targeting YinYang 1[J].Human Cell,2018,31(3):210-219. [30] REN F J,YAO Y,CAI X Y,et al.Emerging role of miR-192-5p in human diseases[J].Frontiers in Pharmacology,2021,12:614068. [31] LIU X L,CAO H X,WANG B C,et al.miR-192-5p regulates lipid synthesis in non-alcoholic fatty liver disease through SCD-1[J].World Journal of Gastroenterology,2017,23(46):8140-8151. [32] PAN Y Y,JING J J,ZHAO J X,et al.microRNA expression patterns in tail fat of different breeds of sheep[J].Livestock Science,2018,207:7-14. [33] GUNS L,CALEBIRO D,LOHSE M J,et al.A cholecystokinin receptor antagonists inhibits chondrocyte hypertrophy and protein kinase a activity decreased induced by activation of GPR22[J].Osteoarthritis and Cartilage,2016,24:S178-S179. [34] CAILOTTO F,LORIES R J.GPR22 overexpression alters the course of chondrogenesis towards chondrocyte hypertrophy and matrix mineralization:A possible link to osteoarthritis?[J].Osteoarthritis and Cartilag,2011,19:S99-S100. [35] MELKMAN-ZEHAVI T,OREN R,KREDO-RUSSO S,et al.miRNAs control insulin content in pancreatic beta-cells via downregulation of transcriptional repressors[J]. EMBO Journal,2011,30(5):835-845. [36] DARMAWI,CHEN L Y,SU P H,et al.BHLHE22 expression is associated with a proinflammatory immune microenvironment and confers a favorable prognosis in endometrial cancer[J].International Journal of Molecular Sciences,2022,23(13):7158. [37] DUGAS J C,IBRAHIM A,BARRES B A.The T3-induced gene KLF9 regulates oligodendrocyte differentiation and myelin regeneration[J].Molecular and Cellular Neuroscience,2012,50(1):45-57. [38] KUREEL J,JOHN A A,PRAKASH R,et al.miR376c inhibits osteoblastogenesis by targeting Wnt3 and ARF-GEF-1-facilitated augmentation of beta-catenin transactivation[J].Journal of Cellular Biochemistry,2018,119(4):3293-3303. [39] TACHEZY M,ZANDER H,MARX A H,et al.ALCAM (CD166) expression and serum levels in pancreatic cancer[J]. PLoS One,2012,7(6):e39018. [40] SANDERS A J,OWEN S,MORGAN L D,et al.Importance of activated leukocyte cell adhesion molecule (ALCAM) in prostate cancer progression and metastatic dissemination[J].Oncotarget,2019,10(59):6362-6377. [41] FERNÁNDEZ M M,FERRAGUT F,DELGADO V M C,et al.Glycosylation-dependent binding of galectin-8 to activated leukocyte cell adhesion molecule (ALCAM/CD166) promotes its surface segregation on breast cancer cells[J].Biochimica et Biophysica Acta,2016,1860(10):2255-2268. [42] FUJIWARA H,TATSUMI K,KOSAKA K,et al.Human blastocysts and endometrial epithelial cells express activated leukocyte cell adhesion molecule (ALCAM/CD166)[J].The Journal of Clinical Endocrinology & Metabolism,2003,88(7):3437-3443. [43] TAN F,GHOSH S,MBEUNKUI F,et al.Essential role for ALCAM gene silencing in megakaryocytic differentiation of K562 cells[J].BMC Molecular Biology,2010,11(1):91. [44] LORENZ K,SICKER M,SCHMELZER E,et al.Multilineage differentiation potential of human dermal skin-derived fibroblasts[J].Experimental Dermatology,2008,17(11):925-932. |